Gelteq begins veterinary clinical trial for antiparasitic drug candidate
Go back to Gelteq begins veterinary clinical trial for antiparasitic drug candidate| (NASDAQ: GELS) | Delayed: 0.73 -0.14 (16.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.87 | 52 Week High | $ | |||
| Open | $0.84 | 52 Week Low | $ | |||
| Day High | $0.84 | P/E | N/A | |||
| Day Low | $0.73 | EPS | $ | |||
| Volume | 159,610 | |||||

